![Badreddin Edris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Badreddin Edris
Fondatore presso
EDGEWISE THERAPEUTICS, INC.
Patrimonio netto: 804 692 $ in data 30/09/2026
Profilo
Badreddin Edris was the founder of Silverback Therapeutics, Inc., founded in 2016, and served as Chief Business Officer in 2018.
Dr. Edris is the founder of Edgewise Therapeutics, Inc., founded in 2017, and holds the title of Independent Non-Executive Director since 2021.
Dr. Edris is the founder of Beeline Medicines Corp., founded in 2025, and holds the titles of President & Chief Operating Officer starting in 2025.
Former jobs include Principal at Genentech Ventures, Inc., Principal at Mission Bay Capital Management, Inc., Chief Operating Officer at Springworks Therapeutics, Inc. from 2021 to 2025, and Principal at OrbiMed Advisors LLC from 2014 to 2018.
Education history includes a graduate degree from Stanford University in 2009, an undergraduate degree from Weber State University in 2007, and a doctorate from Stanford University School of Medicine in 2012.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 19.820 ( 0,02% ) | 804 692 $ | 30/09/2026 |
Posizioni attive di Badreddin Edris
| Società | Posizione | Inizio |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Fondatore | 01/01/2017 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Investitore di Private Equity | 01/02/2026 |
Precedenti posizioni note di Badreddin Edris
| Società | Posizione | Fine |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Direttore operativo | 01/07/2025 |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Corporate Officer/Principal | 01/11/2018 |
| ARS PHARMACEUTICALS, INC. | Fondatore | 01/09/2018 |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Genentech Ventures, Inc.
 Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures invests in companies located in the United States. The firm focuses on biopharmaceuticals and biotechnology sectors. It participates in early stage transactions. | Corporate Officer/Principal | - |
Formazione di Badreddin Edris
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
57
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weber State University
 Weber State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genentech Ventures, Inc.
Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures invests in companies located in the United States. The firm focuses on biopharmaceuticals and biotechnology sectors. It participates in early stage transactions. | Finance |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It provides financing for early stage capital requirements. | Finance |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for treating cancer | Health Technology |
